VYNE Therapeutics Inc. Quarterly Current Ratio in % from Q3 2018 to Q2 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: VYNE Therapeutics Inc. quarterly Current Ratio history and growth rate from Q3 2018 to Q2 2024.
VYNE Therapeutics Inc. Current Ratio for the quarter ending June 30, 2024 was 880 %.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	880			Jun 30, 2024
Q1 2024	831			Mar 31, 2024
Q4 2023	608			Dec 31, 2023
Q3 2023	376			Sep 30, 2023
Q4 2021	346	+26	+8.1%	Dec 31, 2021
Q3 2021	357	+62.5	+21.2%	Sep 30, 2021
Q2 2021	368	+44.1	+13.6%	Jun 30, 2021
Q1 2021	494	+138	+38.8%	Mar 31, 2021
Q4 2020	321	-345	-51.9%	Dec 31, 2020
Q3 2020	294	-841	-74.1%	Sep 30, 2020
Q2 2020	324	-1K	-75.6%	Jun 30, 2020
Q1 2020	356	-1.2K	-77.2%	Mar 31, 2020
Q4 2019	666	-1.09K	-62.1%	Dec 31, 2019
Q3 2019	1.13K	-484	-29.9%	Sep 30, 2019
Q2 2019	1.33K			Jun 30, 2019
Q1 2019	1.56K			Mar 31, 2019
Q4 2018	1.76K			Dec 31, 2018
Q3 2018	1.62K			Sep 30, 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.